Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priyanka Vashisht

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Biological Therapy|April 30, 2013
Omalizumab for treatment of allergic rhinitisPriyanka Vashisht, Thomas Casale
Expert Opinion on Biological Therapy|June 9, 2017
Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differencesPriyanka Vashisht, James O'dell
BMJ Case Reports|March 5, 2013
How far you can trust c-ANCA?Halis Kaan Akturk, Priyanka Vashisht
Rheumatology Advances in Practice|September 16, 2021
A rare overlap of statin-induced anti-3-hydroxy-3-methyl-glutaryl-coenzyme A necrotizing autoimmune myositis and dermatomyositisPriya Parikh, Nneoma Onuorah, Priyanka Vashisht
Thescientificworldjournal|July 17, 2014
Efficient dynamic replication algorithm using agent for data gridPriyanka Vashisht, Rajesh Kumar, Anju Sharma
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 13, 2020
The Diagnostic Conundrum of Felty Syndrome and T-Cell Large Granular Lymphocytic LeukemiaNneoma Onuorah, Hrudya Abraham, Priyanka Vashisht
Arthritis Care & Research|February 12, 2016
Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical TrialsPriyanka Vashisht, Harlan Sayles, Amy C Cannella, et al.
Cureus|April 25, 2017
Toxoplasma Infection in an Immunocompetent Host: Possible Risk of Living with Multiple CatsHalis Kaan Akturk, David Sotello, Allen Ameri, et al.
Annals of the Rheumatic Diseases|November 8, 2015
Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritisTheresa Wampler Muskardin, Priyanka Vashisht, Jessica M Dorschner, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Biological Therapy|April 30, 2013
Omalizumab for treatment of allergic rhinitisPriyanka Vashisht, Thomas Casale
Expert Opinion on Biological Therapy|June 9, 2017
Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differencesPriyanka Vashisht, James O'dell
BMJ Case Reports|March 5, 2013
How far you can trust c-ANCA?Halis Kaan Akturk, Priyanka Vashisht
Rheumatology Advances in Practice|September 16, 2021
A rare overlap of statin-induced anti-3-hydroxy-3-methyl-glutaryl-coenzyme A necrotizing autoimmune myositis and dermatomyositisPriya Parikh, Nneoma Onuorah, Priyanka Vashisht
Thescientificworldjournal|July 17, 2014
Efficient dynamic replication algorithm using agent for data gridPriyanka Vashisht, Rajesh Kumar, Anju Sharma
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|June 13, 2020
The Diagnostic Conundrum of Felty Syndrome and T-Cell Large Granular Lymphocytic LeukemiaNneoma Onuorah, Hrudya Abraham, Priyanka Vashisht
Arthritis Care & Research|February 12, 2016
Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical TrialsPriyanka Vashisht, Harlan Sayles, Amy C Cannella, et al.
Cureus|April 25, 2017
Toxoplasma Infection in an Immunocompetent Host: Possible Risk of Living with Multiple CatsHalis Kaan Akturk, David Sotello, Allen Ameri, et al.
Annals of the Rheumatic Diseases|November 8, 2015
Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid arthritisTheresa Wampler Muskardin, Priyanka Vashisht, Jessica M Dorschner, et al.
Pageof 1